GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 1051 - 1075 of 4050 in total
Antibody Patient Onset (days) ▲ Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgG Patient 3 11 mild
G77974XY
63
IgG Patient 3 11 mild
G78074HX
70
IgG Patient 3 11 mild
G78255UI
48
IgG Patient 3 11 mild
G80587NA
313
IgG Patient 3 11 mild
G81315DD
115
IgG Patient 3 11 mild
G82096UQ
144
IgG Patient 3 11 mild
G82204SH
858
IgG Patient 3 11 mild
G82348BZ
38
IgG Patient 3 11 mild
G82779CI
82
IgG Patient 3 11 mild
G82942ZJ
44
IgG Patient 3 11 mild
G84224TW
149
IgG Patient 3 11 mild
G86156UJ
66
IgG Patient 3 11 mild
G86541PE
180
IgG Patient 3 11 mild
G86566MF
70
IgG Patient 3 11 mild
G89993FE
42
IgG Patient 3 11 mild
G90223GH
45
IgG Patient 3 11 mild
G90562PB
295
IgG Patient 3 11 mild
G91237TK
22411
IgG Patient 3 11 mild
G91537AT
77
IgG Patient 3 11 mild
G92022ML
73
IgG Patient 3 11 mild
G92823JK
55
IgG Patient 3 11 mild
G93351GM
47
IgG Patient 3 11 mild
G94435QH
51
IgG Patient 3 11 mild
G94576MN
81
IgG Patient 3 11 mild
G96557TJ
936

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024